Abstract:ABSTRACT Cutaneous candidiasis, caused by Candida albicans , is a severe and frustrating condition, and finding effective treatments can be challenging. Therefore, the development of farnesol-loaded nanoparticles is an exciting breakthrough. Ethosomes are a novel transdermal drug delivery carrier that incorporates a certain concentration (10–45%) of alcohols into lipid vesicles, resulting in improved permeability and encapsulation rates compared to conventional liposomes. Farnesol is a quorum-sensing molecule involved in morphogenesis regulation in C. albicans , and these ethosomes offer a promising new approach to treating this common fungal infection. This study develops the formulation of farnesol-loaded ethosomes (farnesol-ethosomes) and assesses applications in treating cutaneous candidiasis induced by C. albicans in vitro and in vivo . Farnesol-ethosomes were successfully developed by ethanol injection method. Therapeutic properties of farnesol-ethosomes, such as particle size, zeta potential, and morphology, were well characterized. According to the results, farnesol-ethosomes demonstrated an increased inhibition effect on cells’ growth and biofilm formation in C. albicans . In Animal infection models, treating farnesol-ethosomes by transdermal administration effectively relieved symptoms caused by cutaneous candidiasis and reduced fungal burdens in quantity. We also observed that ethosomes significantly enhanced drug delivery efficacy in vitro and in vivo . These results indicate that farnesol-ethosomes can provide future promising roles in curing cutaneous candidiasis. IMPORTANCE Cutaneous candidiasis attributed to Candida infection is a prevalent condition that impacts individuals of all age groups. As a type of microbial community, biofilms confer benefits to host infections and mitigate the clinical effects of antifungal treatments. In C. albicans , the yeast-to-hypha transition and biofilm formation are effectively suppressed by farnesol through its modulation of multiple signaling pathway. However, the characteristics of farnesol such as hydrophobicity, volatility, degradability, and instability in various conditions can impose limitations on its effectiveness. Nanotechnology holds the potential to enhance the efficiency and utilization of this molecule. Treatment of farnesol-ethosomes by transdermal administration demonstrated a very remarkable therapeutic effect against C. albicans in infection model of cutaneous candidiasis in mice. Many patients suffering fungal skin infection will benefit from this study.

Farnesol as a multifunctional candidate for treatment development

Molecular determinants of cancer cell sensitivity and resistance towards the sesquiterpene farnesol

Molecular docking and dynamics simulation of farnesol as a potential anticancer agent targeting mTOR pathway

Physiological adventures in Candida albicans: farnesol and ubiquinones

Exploring the Potential of Farnesol as a Novel Antifungal Drug and Related Challenges

Repurposing Farnesol for Combating Drug-Resistant and Persistent Single and Polymicrobial Biofilms

Transdermal administration of farnesol-ethosomes enhances the treatment of cutaneous candidiasis induced by Candida albicans in mice

Deciphering farnesol's anti-arthritic and immunomodulatory potential by targeting multiple pathways: a combination of network pharmacology guided exploration and experimental verification

Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway

Absence of farnesol salvage in Candida albicans and probably in other fungi

A critical role of farnesol in the modulation of Amphotericin B and Aureobasidin A antifungal drug susceptibility

The Biomedical Importance of the Missing Pathway for Farnesol and Geranylgeraniol Salvage

Farnesol alleviates diethyl nitrosamine induced inflammation and protects experimental rat hepatocellular carcinoma

Acyclic sesquiterpenes nerolidol and farnesol: mechanistic insights into their neuroprotective potential

Inhibiting Roles Of Farnesol And Hog In Morphological Switching Of Candida Albicans

The investigation of in vitro effects of farnesol at different cancer cell lines

Farnesol and Tyrosol: Secondary Metabolites with a Crucial quorum-sensing Role in Candida Biofilm Development

Enhancement of the antifungal activity of some antimycotics by farnesol and reduction of Candida albicans pathogenicity in a quail model experiment

Farnesol‐Imprinted Nanospheres (FINs) as Quorum Sensing Modulators of Candida albicans Hyphae Formation

Systematic Analysis of Protein Expression in Candida Albicans Exposed to Farnesol

Reduction in Pathogenicity in Yeast-like Fungi by Farnesol in Quail Model